DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /EpigeneticsEpigenetics
  5. /HDACHDAC
  6. /N-hydroxy-4-[[4-(3-methoxyphenyl)phenyl]carbamoylamino]benzamideCAS 2894823-79-9
Chemical structure of CAS 2894823-79-9

N-hydroxy-4-[[4-(3-methoxyphenyl)phenyl]carbamoylamino]benzamide

In Stock•Starting at $230 for 1 mg•Purity ≥ 98%
CAS No.2894823-79-9
MDL No.N/A
MFC21H19N3O4
MW377.40
InChI KeyOPWIKWZVLIWRDK-UHFFFAOYSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98%$230In Stock
5 mg98%$570In Stock
10 mg98%$832In Stock
25 mg98%$1308In Stock
50 mg98%$1725In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2894823-79-9
Product NameN-hydroxy-4-[[4-(3-methoxyphenyl)phenyl]carbamoylamino]benzamide
Heavy Atom Count28Rotatable Bond Count5
Atom Stereo Count0Bond Stereo Count0
HBA4HBD4
TPSA99.690 ŲCharge0
Exact Mass377.13756Complexity969.70
pKa7.130XLogP4.125

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact